Guggenheim Russell Top 50® Mega Cap ETF
Most Recent
Merck & Co.’s Diabetes Products in 3Q17
The combined revenues for Januvia and Janumet decreased 2% at constant exchange rates to $1.52 billion in 3Q17 compared to $1.55 billion in 3Q16.
Johnson & Johnson’s Pharmaceutical Business Performance in 3Q17
JNJ’s pulmonary hypertension products were acquired from Actelion in 2Q17 and reported revenues of $670.0 million during 3Q17.
What Contributed to Pfizer’s Growth in 2016?
The key performers of Pfizer’s product portfolio include Lyrica, Ibrance, Xeljanz, and Eliquis from the Innovative Health business.
How Is Medtronic’s Globalization Strategy Driving Its Growth?
Medtronic’s (MDT) growth is driven by three of the company’s core strategies—therapy innovation, globalization, and economic value.
